Amplification of the MYCN oncogene and consequent over-expression of the N-Myc oncoprotein occur in 20-30% of primary untreated neuroblastoma tissues, and are highly correlated with advanced disease stage as well as poor patient prognosis [1, 2]. The gene discussed is MYCN; the disease is neuroblastoma.